Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle exocytosis (GO:0016079) | 5.86093287 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.80708591 |
3 | vocalization behavior (GO:0071625) | 5.41692539 |
4 | sodium ion export (GO:0071436) | 5.33026795 |
5 | glutamate secretion (GO:0014047) | 5.24516564 |
6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.20133545 |
7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.19672492 |
8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.09869412 |
9 | neuronal action potential propagation (GO:0019227) | 5.01046718 |
10 | synaptic vesicle maturation (GO:0016188) | 4.99308699 |
11 | neuron cell-cell adhesion (GO:0007158) | 4.87722284 |
12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.85971186 |
13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.85952085 |
14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.82946221 |
15 | neurotransmitter secretion (GO:0007269) | 4.70538557 |
16 | protein localization to synapse (GO:0035418) | 4.70100819 |
17 | locomotory exploration behavior (GO:0035641) | 4.69018648 |
18 | regulation of synaptic vesicle transport (GO:1902803) | 4.58107554 |
19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.49482800 |
20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.47412604 |
21 | L-amino acid import (GO:0043092) | 4.36285416 |
22 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.32778623 |
23 | potassium ion homeostasis (GO:0055075) | 4.23083479 |
24 | neuron-neuron synaptic transmission (GO:0007270) | 4.20935771 |
25 | synaptic transmission, glutamatergic (GO:0035249) | 4.13992061 |
26 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.13322781 |
27 | glutamate receptor signaling pathway (GO:0007215) | 4.12980898 |
28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.07579675 |
29 | gamma-aminobutyric acid transport (GO:0015812) | 4.05451753 |
30 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.96557325 |
31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.96329159 |
32 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.96133423 |
33 | exploration behavior (GO:0035640) | 3.95674684 |
34 | cell communication by electrical coupling (GO:0010644) | 3.95639530 |
35 | amino acid import (GO:0043090) | 3.91158527 |
36 | potassium ion import (GO:0010107) | 3.90734163 |
37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.85930998 |
38 | neurotransmitter transport (GO:0006836) | 3.84288449 |
39 | synaptic vesicle endocytosis (GO:0048488) | 3.82427686 |
40 | proline transport (GO:0015824) | 3.76111708 |
41 | cellular sodium ion homeostasis (GO:0006883) | 3.75475068 |
42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.71485507 |
43 | neuromuscular process controlling posture (GO:0050884) | 3.71153889 |
44 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.69799940 |
45 | presynaptic membrane assembly (GO:0097105) | 3.67015724 |
46 | positive regulation of dendritic spine development (GO:0060999) | 3.66746207 |
47 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.66646850 |
48 | neuron recognition (GO:0008038) | 3.63671945 |
49 | neurotransmitter uptake (GO:0001504) | 3.62736557 |
50 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.62715114 |
51 | central nervous system myelination (GO:0022010) | 3.62117407 |
52 | axon ensheathment in central nervous system (GO:0032291) | 3.62117407 |
53 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.59480920 |
54 | long-term synaptic potentiation (GO:0060291) | 3.58386234 |
55 | regulation of synapse structural plasticity (GO:0051823) | 3.56627803 |
56 | regulation of postsynaptic membrane potential (GO:0060078) | 3.55661198 |
57 | regulation of neurotransmitter levels (GO:0001505) | 3.52117014 |
58 | positive regulation of membrane potential (GO:0045838) | 3.51201806 |
59 | presynaptic membrane organization (GO:0097090) | 3.50543697 |
60 | positive regulation of synapse maturation (GO:0090129) | 3.50541452 |
61 | postsynaptic membrane organization (GO:0001941) | 3.49873164 |
62 | layer formation in cerebral cortex (GO:0021819) | 3.49601494 |
63 | regulation of synapse maturation (GO:0090128) | 3.45770039 |
64 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.44496903 |
65 | long-term memory (GO:0007616) | 3.42227108 |
66 | regulation of neurotransmitter secretion (GO:0046928) | 3.41745828 |
67 | auditory behavior (GO:0031223) | 3.41694103 |
68 | transmission of nerve impulse (GO:0019226) | 3.41125653 |
69 | regulation of synaptic plasticity (GO:0048167) | 3.39980821 |
70 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.38893628 |
71 | activation of protein kinase A activity (GO:0034199) | 3.38460501 |
72 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.37837722 |
73 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.37550365 |
74 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.37526711 |
75 | response to histamine (GO:0034776) | 3.35375330 |
76 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.32083884 |
77 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.31441556 |
78 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.29736844 |
79 | cell migration in hindbrain (GO:0021535) | 3.23395884 |
80 | cerebellar granule cell differentiation (GO:0021707) | 3.22677073 |
81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.22403496 |
82 | regulation of neurotransmitter transport (GO:0051588) | 3.20669815 |
83 | regulation of vesicle fusion (GO:0031338) | 3.18669505 |
84 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.17491453 |
85 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.17491453 |
86 | mating behavior (GO:0007617) | 3.17267245 |
87 | membrane depolarization (GO:0051899) | 3.17191182 |
88 | membrane depolarization during action potential (GO:0086010) | 3.16405765 |
89 | detection of calcium ion (GO:0005513) | 3.16204377 |
90 | positive regulation of neurotransmitter transport (GO:0051590) | 3.15378094 |
91 | synaptic transmission (GO:0007268) | 3.14542824 |
92 | regulation of dendritic spine development (GO:0060998) | 3.14301436 |
93 | cellular potassium ion homeostasis (GO:0030007) | 3.14161780 |
94 | regulation of glutamate secretion (GO:0014048) | 3.13491228 |
95 | dendritic spine morphogenesis (GO:0060997) | 3.12727641 |
96 | acidic amino acid transport (GO:0015800) | 3.11179624 |
97 | regulation of ARF protein signal transduction (GO:0032012) | 3.10077191 |
98 | membrane hyperpolarization (GO:0060081) | 3.10047240 |
99 | cell communication involved in cardiac conduction (GO:0086065) | 3.09505362 |
100 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.09071064 |
101 | positive regulation of synapse assembly (GO:0051965) | 3.09032862 |
102 | axonal fasciculation (GO:0007413) | 3.08659365 |
103 | neuromuscular process controlling balance (GO:0050885) | 3.07568561 |
104 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.07308087 |
105 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.07123711 |
106 | cell differentiation in hindbrain (GO:0021533) | 3.07081777 |
107 | transferrin transport (GO:0033572) | 3.06588388 |
108 | establishment of synaptic vesicle localization (GO:0097480) | 3.06308514 |
109 | synaptic vesicle transport (GO:0048489) | 3.06308514 |
110 | synapse assembly (GO:0007416) | 3.06106950 |
111 | behavioral response to cocaine (GO:0048148) | 3.05969130 |
112 | behavioral defense response (GO:0002209) | 3.05466021 |
113 | behavioral fear response (GO:0001662) | 3.05466021 |
114 | startle response (GO:0001964) | 3.02669406 |
115 | positive regulation of synaptic transmission (GO:0050806) | 3.02504046 |
116 | social behavior (GO:0035176) | 3.02177774 |
117 | intraspecies interaction between organisms (GO:0051703) | 3.02177774 |
118 | adult walking behavior (GO:0007628) | 3.01557298 |
119 | neuromuscular process (GO:0050905) | 3.01358316 |
120 | neuromuscular synaptic transmission (GO:0007274) | 3.01303884 |
121 | regulation of respiratory system process (GO:0044065) | 2.99817310 |
122 | regulation of synaptic transmission (GO:0050804) | 2.99290814 |
123 | learning (GO:0007612) | 2.98962510 |
124 | striatum development (GO:0021756) | 2.97061194 |
125 | negative regulation of dendrite development (GO:2000171) | 2.96271620 |
126 | neuronal ion channel clustering (GO:0045161) | 2.94733449 |
127 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.94554123 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.80121786 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.01247186 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.17174695 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04136219 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02070427 |
6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.94724418 |
7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60398183 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.60032929 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.60032929 |
10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58210708 |
11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50103483 |
12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48468038 |
13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46772641 |
14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.45973692 |
15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.45742572 |
16 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.45670023 |
17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.43983331 |
18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43696110 |
19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41923694 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22947894 |
21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16311060 |
22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.15543149 |
23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.13292831 |
24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.10491988 |
25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.10017995 |
26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08664586 |
27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08238065 |
28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.05519183 |
29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.94997133 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89269322 |
31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.80824614 |
32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75302549 |
33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.74548986 |
34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67611444 |
35 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.67226615 |
36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.61544565 |
37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59673694 |
38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57850795 |
39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57801148 |
40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.53772396 |
41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51570710 |
42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46266625 |
43 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.43670253 |
44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41381503 |
45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40681990 |
46 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.36930985 |
47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36733656 |
48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36099909 |
49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35049570 |
50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34851629 |
51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34611074 |
52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33507831 |
53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32653687 |
54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32588384 |
55 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.32176958 |
56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31729762 |
57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28704753 |
58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26013088 |
59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23275745 |
60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23012535 |
61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22999909 |
62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22764882 |
63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21002844 |
64 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20784352 |
65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19181790 |
66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18436376 |
67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17076998 |
68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16926476 |
69 | AR_19668381_ChIP-Seq_PC3_Human | 1.14451895 |
70 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13128017 |
71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11410733 |
72 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09362627 |
73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08031512 |
74 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.07647864 |
75 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06339536 |
76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04195941 |
77 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03234305 |
78 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02239272 |
79 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.01536219 |
80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01524194 |
81 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01385896 |
82 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01083300 |
83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00951819 |
84 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00430620 |
85 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98546859 |
86 | JUN_21703547_ChIP-Seq_K562_Human | 0.97773017 |
87 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96747904 |
88 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96568791 |
89 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96238828 |
90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95818317 |
91 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.95232659 |
92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94815596 |
93 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94447814 |
94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94321582 |
95 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93217198 |
96 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92987345 |
97 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92925290 |
98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91767836 |
99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90107164 |
100 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.88929768 |
101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88677888 |
102 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.88000447 |
103 | KDM2B_26808549_Chip-Seq_REH_Human | 0.84803299 |
104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84708624 |
105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84513277 |
106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.84513277 |
107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84485745 |
108 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.83877003 |
109 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.83864971 |
110 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83327229 |
111 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.82074986 |
112 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.79753797 |
113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79629502 |
114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78785742 |
115 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78623516 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.62017689 |
2 | MP0003880_abnormal_central_pattern | 5.18227098 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.03819350 |
4 | MP0009046_muscle_twitch | 3.57921200 |
5 | MP0004270_analgesia | 3.50040553 |
6 | MP0009745_abnormal_behavioral_response | 3.41513371 |
7 | MP0002064_seizures | 3.32175086 |
8 | MP0002063_abnormal_learning/memory/cond | 3.28119901 |
9 | MP0001968_abnormal_touch/_nociception | 3.27064503 |
10 | MP0002572_abnormal_emotion/affect_behav | 2.92306961 |
11 | MP0002272_abnormal_nervous_system | 2.77158148 |
12 | MP0002736_abnormal_nociception_after | 2.75419066 |
13 | MP0002734_abnormal_mechanical_nocicepti | 2.69881106 |
14 | MP0002735_abnormal_chemical_nociception | 2.56693952 |
15 | MP0005423_abnormal_somatic_nervous | 2.51644600 |
16 | MP0001486_abnormal_startle_reflex | 2.44598929 |
17 | MP0001501_abnormal_sleep_pattern | 2.37835842 |
18 | MP0002822_catalepsy | 2.26692029 |
19 | MP0001440_abnormal_grooming_behavior | 2.25260879 |
20 | MP0002733_abnormal_thermal_nociception | 2.19703922 |
21 | MP0002067_abnormal_sensory_capabilities | 2.19023477 |
22 | MP0006276_abnormal_autonomic_nervous | 2.17506581 |
23 | MP0001970_abnormal_pain_threshold | 2.13333449 |
24 | MP0002184_abnormal_innervation | 1.89708576 |
25 | MP0004924_abnormal_behavior | 1.81970962 |
26 | MP0005386_behavior/neurological_phenoty | 1.81970962 |
27 | MP0008569_lethality_at_weaning | 1.80181833 |
28 | MP0003122_maternal_imprinting | 1.77908259 |
29 | MP0001529_abnormal_vocalization | 1.76853155 |
30 | MP0002557_abnormal_social/conspecific_i | 1.74371735 |
31 | MP0005646_abnormal_pituitary_gland | 1.73520247 |
32 | MP0004142_abnormal_muscle_tone | 1.73245254 |
33 | MP0000778_abnormal_nervous_system | 1.72370293 |
34 | MP0004811_abnormal_neuron_physiology | 1.70220123 |
35 | MP0001984_abnormal_olfaction | 1.69039391 |
36 | MP0003787_abnormal_imprinting | 1.67297533 |
37 | MP0009780_abnormal_chondrocyte_physiolo | 1.65181372 |
38 | MP0005645_abnormal_hypothalamus_physiol | 1.64500549 |
39 | MP0003879_abnormal_hair_cell | 1.59604147 |
40 | MP0000955_abnormal_spinal_cord | 1.59577744 |
41 | MP0003329_amyloid_beta_deposits | 1.58764246 |
42 | MP0003123_paternal_imprinting | 1.58140481 |
43 | MP0002909_abnormal_adrenal_gland | 1.52888448 |
44 | MP0004858_abnormal_nervous_system | 1.50688105 |
45 | MP0002066_abnormal_motor_capabilities/c | 1.45785196 |
46 | MP0002882_abnormal_neuron_morphology | 1.40707973 |
47 | MP0003690_abnormal_glial_cell | 1.36517244 |
48 | MP0001905_abnormal_dopamine_level | 1.30049450 |
49 | MP0000920_abnormal_myelination | 1.27125935 |
50 | MP0002837_dystrophic_cardiac_calcinosis | 1.26830398 |
51 | MP0003633_abnormal_nervous_system | 1.24290266 |
52 | MP0001502_abnormal_circadian_rhythm | 1.22549725 |
53 | MP0000013_abnormal_adipose_tissue | 1.22365257 |
54 | MP0001188_hyperpigmentation | 1.20882321 |
55 | MP0000751_myopathy | 1.13193291 |
56 | MP0004147_increased_porphyrin_level | 1.08566224 |
57 | MP0004885_abnormal_endolymph | 1.06013136 |
58 | MP0002152_abnormal_brain_morphology | 1.05927286 |
59 | MP0003631_nervous_system_phenotype | 1.04956593 |
60 | MP0002229_neurodegeneration | 1.00164057 |
61 | MP0008872_abnormal_physiological_respon | 0.98892446 |
62 | MP0004233_abnormal_muscle_weight | 0.96998289 |
63 | MP0005551_abnormal_eye_electrophysiolog | 0.93421468 |
64 | MP0010386_abnormal_urinary_bladder | 0.93414217 |
65 | MP0004145_abnormal_muscle_electrophysio | 0.93323796 |
66 | MP0002069_abnormal_eating/drinking_beha | 0.92186214 |
67 | MP0002876_abnormal_thyroid_physiology | 0.89945460 |
68 | MP0005171_absent_coat_pigmentation | 0.89661752 |
69 | MP0004742_abnormal_vestibular_system | 0.89476614 |
70 | MP0001963_abnormal_hearing_physiology | 0.87972386 |
71 | MP0005499_abnormal_olfactory_system | 0.87689911 |
72 | MP0005394_taste/olfaction_phenotype | 0.87689911 |
73 | MP0008874_decreased_physiological_sensi | 0.83065346 |
74 | MP0002752_abnormal_somatic_nervous | 0.81898124 |
75 | MP0003634_abnormal_glial_cell | 0.79352362 |
76 | MP0005535_abnormal_body_temperature | 0.76285818 |
77 | MP0004085_abnormal_heartbeat | 0.75411354 |
78 | MP0000631_abnormal_neuroendocrine_gland | 0.74170998 |
79 | MP0003283_abnormal_digestive_organ | 0.72351286 |
80 | MP0008877_abnormal_DNA_methylation | 0.71167788 |
81 | MP0004215_abnormal_myocardial_fiber | 0.68763081 |
82 | MP0003632_abnormal_nervous_system | 0.68732347 |
83 | MP0004484_altered_response_of | 0.67227107 |
84 | MP0001485_abnormal_pinna_reflex | 0.67145208 |
85 | MP0001664_abnormal_digestion | 0.66395274 |
86 | MP0006072_abnormal_retinal_apoptosis | 0.65256169 |
87 | MP0000569_abnormal_digit_pigmentation | 0.64734233 |
88 | MP0001986_abnormal_taste_sensitivity | 0.64690695 |
89 | MP0001943_abnormal_respiration | 0.63818880 |
90 | MP0001299_abnormal_eye_distance/ | 0.63531088 |
91 | MP0001177_atelectasis | 0.63011673 |
92 | MP0003121_genomic_imprinting | 0.62629376 |
93 | MP0003183_abnormal_peptide_metabolism | 0.62467187 |
94 | MP0002638_abnormal_pupillary_reflex | 0.61909112 |
95 | MP0000604_amyloidosis | 0.61448280 |
96 | MP0003137_abnormal_impulse_conducting | 0.60958860 |
97 | MP0003861_abnormal_nervous_system | 0.59896834 |
98 | MP0003646_muscle_fatigue | 0.59696810 |
99 | MP0002653_abnormal_ependyma_morphology | 0.58620624 |
100 | MP0002090_abnormal_vision | 0.58233569 |
101 | MP0004043_abnormal_pH_regulation | 0.56969025 |
102 | MP0005623_abnormal_meninges_morphology | 0.56909897 |
103 | MP0001348_abnormal_lacrimal_gland | 0.56454075 |
104 | MP0010770_preweaning_lethality | 0.56215303 |
105 | MP0002082_postnatal_lethality | 0.56215303 |
106 | MP0010769_abnormal_survival | 0.56087071 |
107 | MP0000579_abnormal_nail_morphology | 0.55211975 |
108 | MP0001346_abnormal_lacrimal_gland | 0.54303916 |
109 | MP0010768_mortality/aging | 0.53589980 |
110 | MP0003956_abnormal_body_size | 0.53196689 |
111 | MP0000026_abnormal_inner_ear | 0.52548340 |
112 | MP0005187_abnormal_penis_morphology | 0.51445895 |
113 | MP0000566_synostosis | 0.50699522 |
114 | MP0005167_abnormal_blood-brain_barrier | 0.46749094 |
115 | MP0003938_abnormal_ear_development | 0.45177072 |
116 | MP0002873_normal_phenotype | 0.43415259 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 8.01306245 |
2 | Myokymia (HP:0002411) | 6.25088275 |
3 | Atonic seizures (HP:0010819) | 5.88374327 |
4 | Focal seizures (HP:0007359) | 5.66073943 |
5 | Febrile seizures (HP:0002373) | 5.27558324 |
6 | Epileptic encephalopathy (HP:0200134) | 5.20139006 |
7 | Visual hallucinations (HP:0002367) | 5.07160590 |
8 | Absence seizures (HP:0002121) | 4.67741539 |
9 | Progressive cerebellar ataxia (HP:0002073) | 4.35132491 |
10 | Dialeptic seizures (HP:0011146) | 4.20125234 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 3.92714924 |
12 | Hyperventilation (HP:0002883) | 3.56132800 |
13 | Action tremor (HP:0002345) | 3.43527392 |
14 | Neurofibrillary tangles (HP:0002185) | 3.41642233 |
15 | Pheochromocytoma (HP:0002666) | 3.34313693 |
16 | Broad-based gait (HP:0002136) | 3.29881372 |
17 | Abnormal eating behavior (HP:0100738) | 3.23608323 |
18 | Gaze-evoked nystagmus (HP:0000640) | 3.23535285 |
19 | Dysdiadochokinesis (HP:0002075) | 3.16708255 |
20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.08556912 |
21 | Neuroendocrine neoplasm (HP:0100634) | 3.03063949 |
22 | Cerebral hypomyelination (HP:0006808) | 3.02268941 |
23 | Supranuclear gaze palsy (HP:0000605) | 3.01608148 |
24 | Truncal ataxia (HP:0002078) | 2.94420653 |
25 | Amblyopia (HP:0000646) | 2.93561214 |
26 | Tetraplegia (HP:0002445) | 2.93128709 |
27 | Poor eye contact (HP:0000817) | 2.91883250 |
28 | Failure to thrive in infancy (HP:0001531) | 2.85436303 |
29 | Depression (HP:0000716) | 2.83734505 |
30 | Anxiety (HP:0000739) | 2.82685883 |
31 | Ankle clonus (HP:0011448) | 2.82199100 |
32 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.82151340 |
33 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.82151340 |
34 | Progressive inability to walk (HP:0002505) | 2.81593991 |
35 | Polyphagia (HP:0002591) | 2.80412486 |
36 | Dysmetria (HP:0001310) | 2.77514516 |
37 | Abnormal social behavior (HP:0012433) | 2.74067753 |
38 | Impaired social interactions (HP:0000735) | 2.74067753 |
39 | Fetal akinesia sequence (HP:0001989) | 2.64090365 |
40 | Obstructive sleep apnea (HP:0002870) | 2.63827532 |
41 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.62177559 |
42 | Epileptiform EEG discharges (HP:0011182) | 2.61705907 |
43 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.59376232 |
44 | Gait imbalance (HP:0002141) | 2.58646063 |
45 | Abnormal hair whorl (HP:0010721) | 2.58344084 |
46 | Scanning speech (HP:0002168) | 2.55433535 |
47 | Limb dystonia (HP:0002451) | 2.55038310 |
48 | Craniofacial dystonia (HP:0012179) | 2.54020583 |
49 | Diplopia (HP:0000651) | 2.49162559 |
50 | Abnormality of binocular vision (HP:0011514) | 2.49162559 |
51 | Abnormality of the lower motor neuron (HP:0002366) | 2.47573647 |
52 | Drooling (HP:0002307) | 2.47013864 |
53 | Excessive salivation (HP:0003781) | 2.47013864 |
54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.45768956 |
55 | Poor suck (HP:0002033) | 2.41130184 |
56 | Postural instability (HP:0002172) | 2.38054796 |
57 | Urinary urgency (HP:0000012) | 2.35338199 |
58 | Genetic anticipation (HP:0003743) | 2.35326846 |
59 | Neuronal loss in central nervous system (HP:0002529) | 2.35204054 |
60 | Impaired smooth pursuit (HP:0007772) | 2.34739322 |
61 | Mutism (HP:0002300) | 2.33961633 |
62 | Termporal pattern (HP:0011008) | 2.33834401 |
63 | Insidious onset (HP:0003587) | 2.33834401 |
64 | Hypsarrhythmia (HP:0002521) | 2.33431691 |
65 | Status epilepticus (HP:0002133) | 2.32770513 |
66 | Dysmetric saccades (HP:0000641) | 2.32600326 |
67 | Spastic tetraparesis (HP:0001285) | 2.32141629 |
68 | Peripheral hypomyelination (HP:0007182) | 2.31619738 |
69 | Rigidity (HP:0002063) | 2.30727063 |
70 | Hemiparesis (HP:0001269) | 2.28665733 |
71 | Bradykinesia (HP:0002067) | 2.27660484 |
72 | Specific learning disability (HP:0001328) | 2.25985881 |
73 | Spastic gait (HP:0002064) | 2.25164319 |
74 | Clonus (HP:0002169) | 2.24543935 |
75 | Congenital primary aphakia (HP:0007707) | 2.23204224 |
76 | Inability to walk (HP:0002540) | 2.22255462 |
77 | Apathy (HP:0000741) | 2.21281182 |
78 | Abnormality of the labia minora (HP:0012880) | 2.15608947 |
79 | Choreoathetosis (HP:0001266) | 2.14841783 |
80 | Annular pancreas (HP:0001734) | 2.14824478 |
81 | Narrow nasal bridge (HP:0000446) | 2.14113715 |
82 | Medial flaring of the eyebrow (HP:0010747) | 2.12278480 |
83 | Impaired vibratory sensation (HP:0002495) | 2.08817051 |
84 | Abnormality of saccadic eye movements (HP:0000570) | 2.08522652 |
85 | Abnormality of the corticospinal tract (HP:0002492) | 2.08502584 |
86 | Torticollis (HP:0000473) | 2.08080325 |
87 | Nephrogenic diabetes insipidus (HP:0009806) | 2.06705402 |
88 | Resting tremor (HP:0002322) | 2.05921925 |
89 | Generalized myoclonic seizures (HP:0002123) | 2.04900061 |
90 | Absent speech (HP:0001344) | 2.04789290 |
91 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.03135921 |
92 | Focal dystonia (HP:0004373) | 2.01982449 |
93 | Hypoventilation (HP:0002791) | 2.01888642 |
94 | Increased circulating renin level (HP:0000848) | 2.01298977 |
95 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.00715703 |
96 | Acute necrotizing encephalopathy (HP:0006965) | 1.99576635 |
97 | Diminished motivation (HP:0000745) | 1.97403076 |
98 | Esotropia (HP:0000565) | 1.96962578 |
99 | Spastic tetraplegia (HP:0002510) | 1.95126495 |
100 | Megalencephaly (HP:0001355) | 1.94918284 |
101 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.94742169 |
102 | Stereotypic behavior (HP:0000733) | 1.94289700 |
103 | Oligomenorrhea (HP:0000876) | 1.93432791 |
104 | CNS hypomyelination (HP:0003429) | 1.93400167 |
105 | Akinesia (HP:0002304) | 1.93330401 |
106 | Agitation (HP:0000713) | 1.92890311 |
107 | Psychosis (HP:0000709) | 1.92835296 |
108 | Progressive macrocephaly (HP:0004481) | 1.92048083 |
109 | Delusions (HP:0000746) | 1.91492755 |
110 | Blue irides (HP:0000635) | 1.91476701 |
111 | Ventricular fibrillation (HP:0001663) | 1.89850553 |
112 | Papilledema (HP:0001085) | 1.89545748 |
113 | Incomplete penetrance (HP:0003829) | 1.88901431 |
114 | Rapidly progressive (HP:0003678) | 1.88842793 |
115 | Lower limb muscle weakness (HP:0007340) | 1.88685196 |
116 | Cerebral inclusion bodies (HP:0100314) | 1.88263066 |
117 | Intention tremor (HP:0002080) | 1.87556221 |
118 | Hemiplegia (HP:0002301) | 1.87161256 |
119 | Protruding tongue (HP:0010808) | 1.86622396 |
120 | Amyotrophic lateral sclerosis (HP:0007354) | 1.86421914 |
121 | Gait ataxia (HP:0002066) | 1.85870181 |
122 | Sleep apnea (HP:0010535) | 1.85130302 |
123 | Muscular hypotonia of the trunk (HP:0008936) | 1.84559640 |
124 | Generalized hypotonia (HP:0001290) | 1.82543620 |
125 | Diminished movement (HP:0002374) | 1.78857587 |
126 | Bundle branch block (HP:0011710) | 1.76728280 |
127 | Postural tremor (HP:0002174) | 1.73286520 |
128 | Paraplegia (HP:0010550) | 1.68561043 |
129 | Prolonged QT interval (HP:0001657) | 1.68320563 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.32307827 |
2 | CASK | 3.44598835 |
3 | MAP3K4 | 3.44452132 |
4 | MAP3K9 | 3.37197886 |
5 | EPHA4 | 3.28109650 |
6 | MAP3K12 | 3.25780063 |
7 | MAP2K7 | 3.04734820 |
8 | MARK1 | 2.75174748 |
9 | MINK1 | 2.70714831 |
10 | MAP2K4 | 2.19836024 |
11 | DAPK2 | 2.15153336 |
12 | CDK19 | 2.12231514 |
13 | DAPK1 | 2.03871732 |
14 | NTRK2 | 1.84917614 |
15 | PLK2 | 1.81105046 |
16 | PAK6 | 1.71090820 |
17 | GRK5 | 1.61282311 |
18 | RIPK4 | 1.56100220 |
19 | PRPF4B | 1.49812962 |
20 | KSR2 | 1.47794614 |
21 | ARAF | 1.47429538 |
22 | NTRK1 | 1.42561466 |
23 | UHMK1 | 1.40551760 |
24 | CDK5 | 1.39405359 |
25 | AKT3 | 1.38402485 |
26 | PNCK | 1.37595624 |
27 | MAPK13 | 1.33234495 |
28 | KSR1 | 1.31546953 |
29 | PRKCG | 1.27855687 |
30 | CAMKK1 | 1.22604525 |
31 | OXSR1 | 1.20858073 |
32 | TNIK | 1.12871596 |
33 | PINK1 | 1.10161227 |
34 | CAMK2A | 1.08469450 |
35 | CAMKK2 | 1.07967589 |
36 | PHKG2 | 1.07561935 |
37 | PHKG1 | 1.07561935 |
38 | SIK2 | 1.07446639 |
39 | STK38 | 1.01950771 |
40 | LATS2 | 0.99786680 |
41 | FES | 0.99130982 |
42 | SGK223 | 0.98384015 |
43 | SGK494 | 0.98384015 |
44 | TYRO3 | 0.97404662 |
45 | NME1 | 0.93272602 |
46 | PRKD3 | 0.93269755 |
47 | CAMK2B | 0.93263685 |
48 | CDK18 | 0.90232979 |
49 | MAP3K6 | 0.89310891 |
50 | ALK | 0.89174244 |
51 | SGK2 | 0.88679850 |
52 | CDK14 | 0.86131292 |
53 | SIK3 | 0.84889999 |
54 | CDK15 | 0.84758404 |
55 | CCNB1 | 0.84391183 |
56 | TNK2 | 0.80857395 |
57 | FGR | 0.80255124 |
58 | CDK11A | 0.72828453 |
59 | MAP3K2 | 0.71839768 |
60 | CAMK4 | 0.71477389 |
61 | BMPR2 | 0.69037363 |
62 | RIPK1 | 0.69012898 |
63 | MAPK12 | 0.67553075 |
64 | STK11 | 0.64692664 |
65 | MAP3K13 | 0.64078884 |
66 | RAF1 | 0.63473537 |
67 | PDK3 | 0.63469495 |
68 | PDK4 | 0.63469495 |
69 | BRAF | 0.62853374 |
70 | SGK1 | 0.62693127 |
71 | PTK2B | 0.62019854 |
72 | NEK1 | 0.61943708 |
73 | SGK3 | 0.61935634 |
74 | CAMK2G | 0.61815569 |
75 | PRKCE | 0.61747605 |
76 | MAPKAPK5 | 0.61608068 |
77 | TSSK6 | 0.60795655 |
78 | FGFR2 | 0.60646165 |
79 | DYRK1A | 0.59759357 |
80 | CAMK2D | 0.59079767 |
81 | LMTK2 | 0.59003669 |
82 | CAMK1 | 0.58799608 |
83 | PRKCH | 0.58535618 |
84 | NEK6 | 0.58257507 |
85 | CSNK1G2 | 0.57234869 |
86 | FER | 0.55396046 |
87 | GRK7 | 0.55341060 |
88 | RET | 0.54111439 |
89 | WNK3 | 0.52707529 |
90 | TAOK1 | 0.51943538 |
91 | PAK3 | 0.51630689 |
92 | BCR | 0.50637691 |
93 | DDR2 | 0.49178863 |
94 | PKN1 | 0.48672166 |
95 | ADRBK1 | 0.47965620 |
96 | IRAK2 | 0.47385369 |
97 | WNK1 | 0.46530420 |
98 | BRSK1 | 0.45981810 |
99 | CDC42BPA | 0.45946725 |
100 | LIMK1 | 0.45267292 |
101 | PRKCZ | 0.44485002 |
102 | MAP3K1 | 0.43084016 |
103 | RPS6KA3 | 0.42615682 |
104 | DYRK2 | 0.41431730 |
105 | MAP2K1 | 0.41329814 |
106 | PDK1 | 0.40336936 |
107 | PDPK1 | 0.39273727 |
108 | CSNK1G3 | 0.39261302 |
109 | ROCK2 | 0.38052055 |
110 | CSNK1E | 0.37980714 |
111 | CAMK1G | 0.37472846 |
112 | MAPK10 | 0.37090191 |
113 | MARK2 | 0.36846891 |
114 | MAP3K11 | 0.36499400 |
115 | PRKCA | 0.35397542 |
116 | FYN | 0.35363187 |
117 | DAPK3 | 0.34682445 |
118 | CSNK1D | 0.33483593 |
119 | PRKG1 | 0.31364790 |
120 | STK39 | 0.31359813 |
121 | PRKACA | 0.29278359 |
122 | PRKCB | 0.29089424 |
123 | CSNK1G1 | 0.28512311 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.13307352 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.98578791 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.83233707 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.78688310 |
5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.67866943 |
6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.62724127 |
7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.54637671 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.52894215 |
9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.51808348 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.42173931 |
11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.39071110 |
12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16333463 |
13 | Taste transduction_Homo sapiens_hsa04742 | 2.07904329 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.05778420 |
15 | Salivary secretion_Homo sapiens_hsa04970 | 1.98296473 |
16 | Insulin secretion_Homo sapiens_hsa04911 | 1.92318674 |
17 | Long-term depression_Homo sapiens_hsa04730 | 1.74134304 |
18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.70713453 |
19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.70364046 |
20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.65990410 |
21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.63923434 |
22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.63747712 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.61182047 |
24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.56599154 |
25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53171301 |
26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.51903123 |
27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.51291627 |
28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49523069 |
29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.46421532 |
30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.35100358 |
31 | Gap junction_Homo sapiens_hsa04540 | 1.33946805 |
32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.32634784 |
33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.30589526 |
34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26389150 |
35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26107137 |
36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23939608 |
37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.22554133 |
38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.14750194 |
39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.14170326 |
40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10541039 |
41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08100870 |
42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04921933 |
43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.02753527 |
44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00326826 |
45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99872462 |
46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97985223 |
47 | Phototransduction_Homo sapiens_hsa04744 | 0.94249377 |
48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94039878 |
49 | Axon guidance_Homo sapiens_hsa04360 | 0.93336982 |
50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.88784353 |
51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86522451 |
52 | Glioma_Homo sapiens_hsa05214 | 0.86209152 |
53 | Melanogenesis_Homo sapiens_hsa04916 | 0.85299763 |
54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83679294 |
55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79406074 |
56 | Huntingtons disease_Homo sapiens_hsa05016 | 0.77031970 |
57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75317349 |
58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72060642 |
59 | Bile secretion_Homo sapiens_hsa04976 | 0.68381438 |
60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67778489 |
61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66747894 |
62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65787678 |
63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63442853 |
64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62394956 |
65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61173622 |
66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61161347 |
67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60389508 |
68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60012366 |
69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54227940 |
70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54173139 |
71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53939325 |
72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51002909 |
73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49246054 |
74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48729462 |
75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48490194 |
76 | Phagosome_Homo sapiens_hsa04145 | 0.48196513 |
77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46466293 |
78 | Alcoholism_Homo sapiens_hsa05034 | 0.46148344 |
79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45507244 |
80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44255035 |
81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42096721 |
82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41239523 |
83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40956222 |
84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40906906 |
85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38124449 |
86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37941785 |
87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37749466 |
88 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37041100 |
89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35693096 |
90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35605111 |
91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35407819 |
92 | Endocytosis_Homo sapiens_hsa04144 | 0.35313895 |
93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33355464 |
94 | Prion diseases_Homo sapiens_hsa05020 | 0.32531675 |
95 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31849602 |
96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31769906 |
97 | Mineral absorption_Homo sapiens_hsa04978 | 0.31208906 |
98 | Tight junction_Homo sapiens_hsa04530 | 0.30939962 |
99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30700612 |
100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29655136 |
101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28617943 |
102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28303430 |
103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28105093 |
104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27704059 |
105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27068962 |
106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26898011 |
107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.26777899 |
108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26348354 |
109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25126886 |
110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25041056 |
111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20964230 |
112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20177577 |
113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19526219 |